BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26751516)

  • 1. Protonation of a glutamate residue modulates the dynamics of the drug transporter EmrE.
    Gayen A; Leninger M; Traaseth NJ
    Nat Chem Biol; 2016 Mar; 12(3):141-5. PubMed ID: 26751516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics underlie the drug recognition mechanism by the efflux transporter EmrE.
    Li J; Her AS; Besch A; Ramirez-Cordero B; Crames M; Banigan JR; Mueller C; Marsiglia WM; Zhang Y; Traaseth NJ
    Nat Commun; 2024 May; 15(1):4537. PubMed ID: 38806470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrostatic lock in the transport cycle of the multidrug resistance transporter EmrE.
    Vermaas JV; Rempe SB; Tajkhorshid E
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7502-E7511. PubMed ID: 30026196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric protonation of EmrE.
    Morrison EA; Robinson AE; Liu Y; Henzler-Wildman KA
    J Gen Physiol; 2015 Dec; 146(6):445-61. PubMed ID: 26573622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structured loop modulates coupling between the substrate-binding and dimerization domains in the multidrug resistance transporter EmrE.
    Banigan JR; Gayen A; Cho MK; Traaseth NJ
    J Biol Chem; 2015 Jan; 290(2):805-14. PubMed ID: 25406320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charge neutralization of the active site glutamates does not limit substrate binding and transport by small multidrug resistance transporter EmrE.
    Spreacker PJ; Brousseau M; Hisao GS; Soltani M; Davis JH; Henzler-Wildman KA
    J Biol Chem; 2023 Feb; 299(2):102805. PubMed ID: 36529287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric protonation of glutamate residues drives a preferred transport pathway in EmrE.
    Li J; Sae Her A; Traaseth NJ
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34607959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precious things come in little packages.
    Schuldiner S; Granot D; Steiner S; Ninio S; Rotem D; Soskin M; Yerushalmi H
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):155-62. PubMed ID: 11321568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New free-exchange model of EmrE transport.
    Robinson AE; Thomas NE; Morrison EA; Balthazor BM; Henzler-Wildman KA
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10083-E10091. PubMed ID: 29114048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C terminus of the bacterial multidrug transporter EmrE couples drug binding to proton release.
    Thomas NE; Wu C; Morrison EA; Robinson AE; Werner JP; Henzler-Wildman KA
    J Biol Chem; 2018 Dec; 293(49):19137-19147. PubMed ID: 30287687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate-induced tryptophan fluorescence changes in EmrE, the smallest ion-coupled multidrug transporter.
    Elbaz Y; Tayer N; Steinfels E; Steiner-Mordoch S; Schuldiner S
    Biochemistry; 2005 May; 44(19):7369-77. PubMed ID: 15882076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Few Conserved Amino Acids in the Small Multidrug Resistance Transporter EmrE Influence Drug Polyselectivity.
    Saleh M; Bay DC; Turner RJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic conformational plasticity of native EmrE provides a pathway for multidrug resistance.
    Cho MK; Gayen A; Banigan JR; Leninger M; Traaseth NJ
    J Am Chem Soc; 2014 Jun; 136(22):8072-80. PubMed ID: 24856154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli.
    Ma C; Chang G
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2852-7. PubMed ID: 14970332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transported substrate determines exchange rate in the multidrug resistance transporter EmrE.
    Morrison EA; Henzler-Wildman KA
    J Biol Chem; 2014 Mar; 289(10):6825-6836. PubMed ID: 24448799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protonation-dependent conformational dynamics of the multidrug transporter EmrE.
    Dastvan R; Fischer AW; Mishra S; Meiler J; Mchaourab HS
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1220-5. PubMed ID: 26787875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking dynamics of the SMR transporter EmrE impairs efflux activity.
    Dutta S; Morrison EA; Henzler-Wildman KA
    Biophys J; 2014 Aug; 107(3):613-620. PubMed ID: 25099800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced conformational changes of the multidrug resistance transporter EmrE probed by oriented solid-state NMR spectroscopy.
    Gayen A; Banigan JR; Traaseth NJ
    Angew Chem Int Ed Engl; 2013 Sep; 52(39):10321-4. PubMed ID: 23939862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducing conformational preference of the membrane protein transporter EmrE through conservative mutations.
    Leninger M; Sae Her A; Traaseth NJ
    Elife; 2019 Oct; 8():. PubMed ID: 31637997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sequence bias in the topology of the multidrug transporter EmrE.
    McHaourab HS; Mishra S; Koteiche HA; Amadi SH
    Biochemistry; 2008 Aug; 47(31):7980-2. PubMed ID: 18616286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.